
Work Here?
Temporary placeholder
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Orlando, Florida
Founded
2008
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
LUBBOCK, Texas, February 28, 2025 (Newswire.com) - MicroGenDX, a leader in clinical molecular diagnostics, is launching Rapid H5, a qPCR test designed to detect H5 avian influenza A variants, such as H5N1, the current bird flu strain.
MicroGenDX launches its Patient-Focused Website to streamline Access to Microbial Testing.
A new study from UCLA and MicroGenDX shows that bacteria may be one of the factors holding back male fertilityORLANDO, FL / ACCESSWIRE / January 31, 2024 / A groundbreaking study conducted by researchers at the University of California Los Angeles (UCLA) and MicroGenDX unveils a potential link between bacterial profiles and male infertility. The collaborative effort, highlighted in the study Semen microbiota are dramatically altered in men with abnormal sperm parameters by Osadchiy et al., sheds crucial light on microbial variations associated with abnormal sperm parameters. This significant discovery not only deepens our comprehension of male infertility, but also provides a new exploratory avenue for treatments facilitated by MicroGenDX's advanced testing.Differential Relative Abundance. Only statistically significant differences are shown. Figure 1A-C, represent the comparisons of groups 1, 2 and 3, respectively.While pollution and other environmental factors have long been recognized as contributors to declining sperm counts, the revelation of bacterial involvement poses a new challenge in the battle against male infertility. Male fertility concerns have historically weighed heavily on individuals whose aspirations of fatherhood are jeopardized by factors often beyond their control
Evvy, a female-founded startup on a mission to close the gender health gap by discovering and leveraging female-specific biomarkers, is now partnering with MicroGenDX, a CLIA/CAP certified laboratory that has been pioneering the use of NGS testing for physicians for over a decade.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Orlando, Florida
Founded
2008
Find jobs on Simplify and start your career today